MAPT and Alzheimer disease: The elevated VILIP-1 levels were significantly correlated with higher p-tau-181 and a reduced Aβ42/Aβ40 ratio in the Alzheimer’s disease patients, indicating its role in the pathophysiology of the disease [334].